These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
    Author: Priano L, Albani G, Calderoni S, Baudo S, Lopiano L, Rizzone M, Astolfi V, Cavalli R, Gasco MR, Fraschini F, Bergamasco B, Mauro A.
    Journal: Neurol Sci; 2002 Sep; 23 Suppl 2():S99-100. PubMed ID: 12548362.
    Abstract:
    This study evaluated the efficacy in Parkinson's disease (PD) of a new pharmacologic preparation of apomorphine included in microemulsions and administered by transdermal route, which provides a constant release of the drug for several hours (Apo-TD). Twenty-one PD patients with motor fluctuations were treated with L-dopa alone, with L-dopa plus oral dopamine-agonists, or with L-dopa plus Apo-TD. Apo-TD improved UPDRS-III and tapping test scores in "off" conditions, and reduced duration of "off" periods; no improvement in "on" conditions occurred. We conclude that Apo-TD shows its efficacy particularly by reducing "off" period duration and disability rather than improving motor performances in "on" conditions and therefore it seems a promising treatment for uncontrolled "off" phases in PD patients.
    [Abstract] [Full Text] [Related] [New Search]